Affluent Medical S.A.
AFME.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €577 | €4,118 | €661 | €634 |
| % Growth | -86% | 523% | 4.3% | – |
| Cost of Goods Sold | €1,719 | €12,289 | €1,101 | €1,247 |
| Gross Profit | -€1,142 | -€3,303 | -€440 | -€613 |
| % Margin | -197.9% | -80.2% | -66.6% | -96.7% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €6,495 | €7,212 | €6,154 |
| SG&A Expenses | €6,796 | €6,574 | €7,229 | €6,182 |
| Sales & Mktg Exp. | €0 | €79 | €17 | €28 |
| Other Operating Expenses | -€4,180 | -€8,492 | €1,138 | €1,235 |
| Operating Expenses | €2,616 | -€1,918 | €8,367 | €7,417 |
| Operating Income | -€9,727 | -€6,132 | -€9,557 | -€7,973 |
| % Margin | -1,685.8% | -148.9% | -1,445.8% | -1,257.6% |
| Other Income/Exp. Net | -€252 | €145 | -€537 | -€979 |
| Pre-Tax Income | -€9,979 | -€5,987 | -€10,094 | -€8,952 |
| Tax Expense | -€607 | -€616 | -€726 | -€72 |
| Net Income | -€9,372 | -€5,371 | -€9,368 | -€7,673 |
| % Margin | -1,624.3% | -130.4% | -1,417.2% | -1,210.3% |
| EPS | -0.24 | -0.14 | -0.29 | -0.25 |
| % Growth | -71.4% | 51.7% | -16% | – |
| EPS Diluted | -0.24 | -0.14 | -0.29 | -0.25 |
| Weighted Avg Shares Out | 39,348 | 39,346 | 32,304 | 30,403 |
| Weighted Avg Shares Out Dil | 39,348 | 39,346 | 32,788 | 30,929 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €700 | -€497 | €739 | €0 |
| Depreciation & Amortization | €1,173 | €1,194 | €1,202 | €1,028 |
| EBITDA | -€8,106 | -€5,177 | -€8,266 | -€6,945 |
| % Margin | -1,404.9% | -125.7% | -1,250.5% | -1,095.4% |